내시경 점막하 박리술 후 점막 고유층에 재발한 조기위암 1예

Local Recurrence of EGC after ESD

  • 이상훈 (가톨릭대학교 의과대학 내과학교실) ;
  • 정진환 (가톨릭대학교 의과대학 내과학교실) ;
  • 송준호 (가톨릭대학교 의과대학 내과학교실) ;
  • 김정호 (가톨릭대학교 의과대학 내과학교실) ;
  • 정대영 (가톨릭대학교 의과대학 내과학교실) ;
  • 김진일 (가톨릭대학교 의과대학 내과학교실) ;
  • 박수헌 (가톨릭대학교 의과대학 내과학교실) ;
  • 김재광 (가톨릭대학교 의과대학 내과학교실)
  • Lee, Sang-Hun (Department of Internal Medicine, The Catholic University of Korea College of Medicine) ;
  • Jung, Jin-Hwan (Department of Internal Medicine, The Catholic University of Korea College of Medicine) ;
  • Song, Jun-Ho (Department of Internal Medicine, The Catholic University of Korea College of Medicine) ;
  • Kim, Jeong-Ho (Department of Internal Medicine, The Catholic University of Korea College of Medicine) ;
  • Cheung, Dae-Young (Department of Internal Medicine, The Catholic University of Korea College of Medicine) ;
  • Kim, Jin-Il (Department of Internal Medicine, The Catholic University of Korea College of Medicine) ;
  • Park, Soo-Heon (Department of Internal Medicine, The Catholic University of Korea College of Medicine) ;
  • Kim, Jae-Kwang (Department of Internal Medicine, The Catholic University of Korea College of Medicine)
  • 발행 : 2011.02.27

초록

내시경 점막 절제술은 미분화 조직 형태의 조기위암에서는 림프절 전이가 상대적으로 높아서 수술의 대체 치료법으로 받아들여지지 않고 있다. 최근 개발된 내시경 점막하 박리술로 큰 점막 병변 혹은 궤양을 동반한 병변의 완전 절제가 가능하나 치료 적응증은 림프절 전이가 없는 조기위암에 한정된다. 만약 림프절 전이의 위험도가 낮은 환자군을 규명한다면 내시경 점막하 박리술이 수술 치료법을 대체할 수 있을 것이다. 또한 내시경 점막하 박리술은 조직의 정확한 평가와 잔존암 및 재발을 예방할 수 있다. 저자들은 미분화 조기위암을 내시경 점막하 박리술로 완전 절제한 후, 림프절 전이를 동반하지 않고 박리술 반흔 조직검사에서 점막 고유층에서 재발한 1예를 경험하였기에 문헌고찰과 함께 이를 보고한다.

Endoscopic mucosal resection is not accepted as an alternative to surgery for treating EGC of the undifferentiated histologic type because of the relatively higher probability of lymph node metastasis with the endoscopic procedure. The recently developed endoscopic submucosal dissection (ESD) techniques have made en-bloc resection of large intramucosal or ulcerated lesions feasible, but the procedure's therapeutic indications are limited to EGC without lymph node metastasis. If we could define a subgroup of patients who have undifferentiated EGC with a low-risk of lymph node metastasis, then the application of ESD would be possible instead of surgery. ESD also allows precise histologic assessment of resected specimens and it may prevent residual disease and local recurrence. We report on a case that poorly differentiated adenocarcinoma was curatively removed by ESD, but cancer recurrence was detected in the lamina propria of the post ESD scar without lymph node metastasis or intraluminal lesions three years after the ESD.

키워드

참고문헌

  1. Gotoda T, Yamamoto H, Soetikno RM. Endoscopic submucosal dissection of early gastric cancer. J Gastroenterol 2006;41:929-942. https://doi.org/10.1007/s00535-006-1954-3
  2. Takeuchi Y, Uedo N, Iishi H, et al. Endoscopic submucosal dissection with insulated-tip knife for large mucosal early gastric cancer: a feasibility study (with videos). Gastrointest Endosc 2007;66:186-193. https://doi.org/10.1016/j.gie.2007.03.1059
  3. Eguchi T, Gotoda T, Oda I, Hamanaka H, Hasuike N, Saito D. Is endoscopic one-piece mucosal resection essential for early gastric cancer? Dig Endosc 2003;15:113-116. https://doi.org/10.1046/j.1443-1661.2003.00227.x
  4. Gotoda T, Yanagisawa A, Sasako M, et al. Incidence of lymph node metastasis from early gastric cancer: Estimation with a large number of cases at two large centers. Gastric Cancer 2000;3:219-225. https://doi.org/10.1007/PL00011720
  5. Yasuda K, Shiraishi N, Suematsu T, Yamaguchi K, Adachi Y, Kitano S. Rate of detection of lymph node metastasis is correlated with the depth of submucosal invasion in early stage gastric carcinoma. Cancer 1999;85:2119-2123. https://doi.org/10.1002/(SICI)1097-0142(19990515)85:10<2119::AID-CNCR4>3.0.CO;2-M
  6. Nakajima T, Oda I, Gotoda T, et al. Metachronous gastric cancers after endoscopic resection: how effective is annual endoscopic surveillance? Gastric Cancer 2006;9:93-98. https://doi.org/10.1007/s10120-006-0372-9
  7. Seo JH, Kim N, Lee DH, et al. Clinical feature and recent treatment of gastric cancer. Korean J Med 2006;71:149-157.
  8. Ishikawa S, Togashi A, Inoue M, et al. Indications for EMR/ESD in cases of early gastric cancer: relationship between histological type, depth of wall invasion, and lymph node metastasis. Gastric Cancer 2007;10:35-38. https://doi.org/10.1007/s10120-006-0407-2
  9. Yamao T, Shirao K, Ono H, et al. Risk factors for lymph node metastasis from intramucosal gastric carcinoma. Cancer 1996;77:602-606. https://doi.org/10.1002/(SICI)1097-0142(19960215)77:4<602::AID-CNCR3>3.0.CO;2-I
  10. Li H, Lu P, Lu Y, et al. Predictive factors for lymph node metastasis in poorly differentiated early gastric cancer and their impact on the surgical strategy. World J Gastroenterology 2008;14:4222-4226. https://doi.org/10.3748/wjg.14.4222
  11. Ye BD, Kim SG, Lee JY, et al. Predictive factors for lymph node metastasis and endoscopic treatment strategies for undifferentiated early gastric cancer. J Gastroenterol and Hepatol 2008;23:46-50. https://doi.org/10.1111/j.1440-1746.2007.05275.x
  12. Isomoto H, Shikuwa S, Yamaguchi N, et al. Endoscopic submucosal dissection for early gastric cancer: a large-scale follow-up study. Gut 2009;58:331-336. https://doi.org/10.1136/gut.2008.165381
  13. Arima N, Adachi K, Katsube T, et al. Predictive factors for metachronous recurrence of early gastric cancer after endoscopic treatment. J Clin Gastroenterol 1999;29:44-47. https://doi.org/10.1097/00004836-199907000-00011
  14. Seo JH, Park JC, Kim YJ, Shin SK, Lee YC, Lee SK. Undifferentiated histology after endoscopic resection may predict synchronous and metachronous occurrence of early gastric cancer. Digestion 2010;81:35-42. https://doi.org/10.1159/000235921
  15. Ninomiya A, Yanagisawa Y, Kato Y, Tomimatsu H. Unrecognizable intramucosal spread of diffuse-type mucosal gastric carcinoma of less than 20 mm in size. Endoscopy 2000;32:604-608. https://doi.org/10.1055/s-2000-16506